Joel Gunnarsson
Overview
Explore the profile of Joel Gunnarsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franchi M, Gunnarsson J, Gonzales-Parra E, Ferreira A, Strom O, Corrao G
J Clin Endocrinol Metab
. 2023 May;
108(11):e1424-e1432.
PMID: 37235771
Context: Secondary hyperparathyroidism (SHPT) is a complication of chronic kidney disease (CKD) affecting mineral and bone metabolism and characterized by excessive parathyroid hormone (PTH) production and parathyroid hyperplasia. Objective: The...
2.
Nystrom T, Grip E, Gunnarsson J, Casajust P, Karlsdotter K, Skogsberg J, et al.
Diabetes Obes Metab
. 2022 Sep;
25(1):261-271.
PMID: 36097728
Aims: To evaluate effectiveness and healthcare resource utilization (HCRU) of empagliflozin versus dipeptidyl peptidase-4 inhibitors (DPP-4i) in Swedish clinical practice, as part of the EMPRISE EU study (EUPAS27606, NCT03817463). Materials...
3.
Bover J, Gunnarsson J, Csomor P, Kaiser E, Cianciolo G, Lauppe R
Clin Kidney J
. 2021 Oct;
14(10):2177-2186.
PMID: 34603696
Background: Secondary hyperparathyroidism (SHPT) is a common and major complication in chronic kidney disease (CKD), reflecting the increase of parathyroid hormone (PTH) in response to reduced vitamin D signalling and...